Functional validation of tensin2 SH2-PTB domain by CRISPR/Cas9-mediated genome editing-Reference-Cited by-同舟云学术

Functional validation of tensin2 SH2-PTB domain by CRISPR/Cas9-mediated genome editing

Published:2016 Issue:9 Volume:78 Page:1413-1420
ISSN:0916-7250
Container-title:Journal of Veterinary Medical Science
language:en
Short-container-title:The Journal of Veterinary Medical Science

Author:

MARUSUGI Kiyoma¹,NAKANO Kenta¹²,SASAKI Hayato¹,KIMURA Junpei³,YANOBU-TAKANASHI Rieko²⁴,OKAMURA Tadashi²⁴,SASAKI Nobuya¹

Affiliation:

1. Laboratory of Laboratory Animal Science and Medicine, School of Veterinary Medicine, Kitasato University, Towada, Aomori 034-8628, Japan

2. Department of Laboratory Animal Medicine, Research Institute, National Center for Global Health and Medicine, Tokyo 162–8655, Japan

3. Laboratory of Anatomy, Department of Biomedical Sciences, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Hokkaido 060–0818, Japan

4. Department of Infectious Diseases, Section of Animal Models, Research Institute, National Center for Global Health and Medicine, Tokyo 162–8655, Japan

Publisher

Japanese Society of Veterinary Science

Subject

General Veterinary

Link

https://www.jstage.jst.go.jp/article/jvms/78/9/78_16-0205/_pdf

Reference38 articles.

1. 1. Akilesh, S., Suleiman, H., Yu, H., Stander, M. C., Lavin, P., Gbadegesin, R., Antignac, C., Pollak, M., Kopp, J. B., Winn, M. P. and Shaw, A. S. 2011. Arhgap24 inactivates Rac1 in mouse podocytes, and a mutant form is associated with familial focal segmental glomerulosclerosis. J. Clin. Invest. 121: 4127–4137.

2. 2. Basak, P., Dillon, R., Leslie, H., Raouf, A. and Mowat, M. R. 2015. The Deleted in Liver Cancer 1 (Dlc1) tumor suppressor is haploinsufficient for mammary gland development and epithelial cell polarity. BMC Cancer 15: 630.

3. 3. Calderwood, D. A., Fujioka, Y., de Pereda, J. M., García-Alvarez, B., Nakamoto, T., Margolis, B., McGlade, C. J., Liddington, R. C. and Ginsberg, M. H. 2003. Integrin beta cytoplasmic domain interactions with phosphotyrosine-binding domains: a structural prototype for diversity in integrin signaling. Proc. Natl. Acad. Sci. U.S.A. 100: 2272–2277.

4. 4. Chan, L. K., Ko, F. C., Ng, I. O. and Yam, J. W. 2009. Deleted in liver cancer 1 (DLC1) utilizes a novel binding site for Tensin2 PTB domain interaction and is required for tumor-suppressive function. PLOS ONE 4: e5572.

5. 5. Chen, H. and Lo, S. H. 2003. Regulation of tensin-promoted cell migration by its focal adhesion binding and Src homology domain 2. Biochem. J. 370: 1039–1045.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tensins in Kidney Function and Diseases;Life;2023-05-24

2. Tensin 2-deficient nephropathy: mechanosensitive nephropathy, genetic susceptibility;Experimental Animals;2022

3. Tensins – emerging insights into their domain functions, biological roles and disease relevance;Journal of Cell Science;2021-02-15

4. Lycopene attenuates high glucose‑mediated apoptosis in MPC5 podocytes by promoting autophagy via the PI3K/AKT signaling pathway;Experimental and Therapeutic Medicine;2020-07-13

5. New Role for Growth/Differentiation Factor 15 in the Survival of Transplanted Brown Adipose Tissues in Cooperation with Interleukin-6;Cells;2020-06-01